Latest Regulatory Approval News

Paradigm Biopharmaceuticals has entered a binding agreement with AVet Health to co-develop and license a novel oral therapy for veterinary osteoarthritis in Australia and New Zealand, unlocking new market potential while advancing its human clinical trials.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

Olympio Metals has confirmed promising high-grade gold soil anomalies at its Bousquet Gold Project in Quebec, highlighting a new priority target and preparing to resume drilling following significant historical intercepts.

Audalia Resources has released supplementary details to its January 2026 Prefeasibility Study update, confirming a maiden ore reserve and outlining plans for construction to begin in late 2026, contingent on funding and approvals.

Canyon Resources updates progress on its Minim Martap Bauxite Project, confirming key milestones despite locomotive delivery delays that push the maiden bauxite shipment to Q3 2026.

Iris Cairns Property Trust has confirmed new funding arrangements and plans to extend its takeover offer period for Reef Casino Trust, navigating regulatory hurdles and reassuring investors of its financial backing.

Memphasys has raised $800,000 through a share placement to accelerate the commercial expansion of its Felix™ System, following key regulatory approvals and initial revenue milestones.

Macro Metals Limited has secured shareholder approval for a A$5.3 million budget to push the Extension Iron Ore Project in Western Australia towards mine construction readiness, marking a significant step in its development.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

HMC Capital has forged a strategic partnership with global investor KKR, securing up to $603 million to expand its Energy Transition Platform focused on battery storage and wind projects. This deal aims to boost Australia’s renewable capacity while enhancing shareholder returns.

Ore Resources has acquired an additional mining lease within its Miriam Gold Project, consolidating tenure over the promising Canyon prospect. The company plans an extensive 30,000m drilling program in 2026 to further explore this fertile gold system.

Apiam Animal Health Limited has announced a special fully franked dividend of AUD 0.10 per share, with payment scheduled for mid-February 2026. Notably, the company has suspended its dividend reinvestment plan for this payout.